Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
$0.00
$0.00
$0.00
$0.00
$28K2.0812,718 shsN/A
QTXB
QuantRx Biomedical
$0.00
$0.00
$0.00
$39K-4.326,433 shsN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
$0.00
$0.00
$0.00
$17K-18.9117,300 shsN/A
SDCCQ
SmileDirectClub
$0.00
$0.00
$0.01
$40K1.8764,863 shsN/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
0.00%0.00%0.00%-33.33%-33.33%
QTXB
QuantRx Biomedical
0.00%0.00%0.00%-80.00%-97.50%
Regenicin, Inc. stock logo
RGIN
Regenicin
0.00%0.00%0.00%0.00%-98.00%
SDCCQ
SmileDirectClub
0.00%0.00%0.00%0.00%-96.43%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
QTXB
QuantRx Biomedical
N/AN/AN/AN/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
0.00
N/AN/AN/A
QTXB
QuantRx Biomedical
0.00
N/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
0.00
N/AN/AN/A
SDCCQ
SmileDirectClub
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
$270K0.11N/AN/AN/A
QTXB
QuantRx Biomedical
N/AN/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
$470.74M0.00N/AN/AN/ANaN
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
-$510KN/A0.00N/AN/AN/AN/AN/A
QTXB
QuantRx Biomedical
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
-$640KN/A0.00N/AN/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
-$86.40MN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
N/AN/AN/AN/AN/A
QTXB
QuantRx Biomedical
N/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
N/A
QTXB
QuantRx Biomedical
N/A
Regenicin, Inc. stock logo
RGIN
Regenicin
0.01%
SDCCQ
SmileDirectClub
0.07%

Insider Ownership

CompanyInsider Ownership
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
34.11%
QTXB
QuantRx Biomedical
21.90%
Regenicin, Inc. stock logo
RGIN
Regenicin
N/A
SDCCQ
SmileDirectClub
64.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Advanced BioMedical Technologies, Inc. stock logo
ABMT
Advanced BioMedical Technologies
2070.91 millionN/ANot Optionable
QTXB
QuantRx Biomedical
N/A78.70 millionN/ANot Optionable
Regenicin, Inc. stock logo
RGIN
Regenicin
3165.77 millionN/ANot Optionable
SDCCQ
SmileDirectClub
2,700402.61 million142.12 millionOptionable

New MarketBeat Followers Over Time

Top Headlines

View All Headlines
Advanced BioMedical Technologies stock logo

Advanced BioMedical Technologies OTCMKTS:ABMT

$0.0004 0.00 (0.00%)
As of 05/29/2025

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

QuantRx Biomedical OTCMKTS:QTXB

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Regenicin stock logo

Regenicin OTCMKTS:RGIN

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

SmileDirectClub NASDAQ:SDCCQ

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee. On January 26, 2024, the voluntary petition of SmileDirectClub, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 29, 2023..